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A BST R AC T   
 
Aim: In this study, the serological values of our patients followed up with a diagnosis of migraine were 
compared with the results of healthy controls in terms of possible association with intracellular pathogens, 
Toxoplasma gondii and Borrelia burgdorferi. 
Methods: Fifty patients with migraine, randomly selected among migraine patients without any additional 
disease, who applied to Bolu Abant Izzet Baysal Training and Research Hospital between January 1, 2015 and 
August 31, 2019 were included in the study. Fifty subjects without headache were included as control group. 
The history of infectious diseases of the patient and control groups (Toxoplasma gondii, Borrelia burgdorferi- 
causing Lyme disease) was determined by serological diagnostic methods. 
Results: The study group consisted of 64 women with a mean age of 45.5±13.1 (15-76) years. Migraine and 
control groups were found to be similar in terms of age (p=0.059) and gender (p=0.211) distributions. The 
frequency of Toxoplasma gondii positivity in the migraine group was 28% (n=14) and 10% (n=5) in the control 
group. The frequency of Lyme was 19.6% (n=11) in the migraine group and 14.3% (n=8) in the control group. 
The frequency of Toxoplasma gondii positivity was statistically significantly higher in the migraine group 
(p=0.022), while the frequency of Lyme was found to be similar in the migraine and control groups (p=0.450). 
Conclusion: The results of our study suggest that there are statistically significant differences between 
migraine and control groups only in terms of Toxoplasma gondii positivity rates, not Lyme. However, we 
believe that larger sample studies are needed to determine the detailed relationship between migraine and 
Toxoplasma gondii infection. 
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Introduction 
Migraine is a form of recurrent headache 
experienced by approximately 10% of the 
population, with a 3:1 female-to-male ratio [1]. 
It is renowned for severely disabling headache 
attacks which last 4–72 hours, are often 
unilateral, and are exacerbated by routine 
physical activity. These attacks can also be 
associated with nausea, photophobia or 
phonophobia [2]. 
Many factors, like foods, psychosocial stress, 
lifestyle factors and smoking have been 
suggested to trigger migraine [3]. More 
interestingly, it has been emphasized that some 
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infections, such as Toxoplasma gondii (causing 
Toxoplasmosis), can be associated with 
migraine and it has also been reported that some 
infections can mimic the clinical features of 
migraine [4-6]. Therefore, screening patients 
diagnosed with migraine in terms of these 
infections may be beneficial for diagnosis and 
treatment in migraine. Although the 
relationship between Toxoplasma gondii and 
migraine has been studied relatively more 
frequently, there are very few studies 
examining the relationship between migraine 
and other diseases caused by intracellular 
pathogens, such as Lyme [5,6]. Lyme disease, 
usually caused by infection with the spirochete 
Borrelia burgdorferi, is a multisystem disease 
caused by the body's immune response to 
infection [7]. These patients may present with 
physical findings such as headache, 
meningismus and cranioneuropathy as a sign of 
aseptic meningitis [7,8]. 
In this study, the serological values of our 
patients followed up with a diagnosis of 
migraine were compared with the results of 
healthy controls in terms of possible association 
with intracellular pathogens, Toxoplasma 
gondii and Borrelia burgdorferi. 
 
Materials and methods 
Patient and control groups 
In this study, patients with migraine who had 
applied to the Neurology Clinic of Bolu Abant 
Izzet Baysal Training and Research Hospital, 
between January 1, 2015 and August 31, 2019 
were included. A healthy control group 
comprised of patients who had applied to the 
clinic in the study period were also included. 
Between the specified dates, a total of 50 
patients with migraine attended follow-up or 
were newly diagnosed. Additionally, patients 
without migraine who had been admitted for 
other symptoms but were not diagnosed with 
any neurological condition were included as 
healthy controls. Among these, patients with 
any other chronic diseases, history of surgery or 
malignancy, those with other neurological or 
psychiatric diagnoses, and individuals who 
refused to participate in the study were 
excluded from the analyses. A final total of 50 
patients with migraine and 50 controls had 
undergone serological analyses for 
Toxoplasmosis and Lyme. 
Necessary permissions were obtained from the 
Clinical Research Ethics Committee of Bolu 
Abant Izzet Baysal University to conduct the 
study. (Approval number: 2020/245, Approval 
date: 13/10/2020) and all the patients were 
informed about the study and their written 
informed consents were obtained. 
 
Serological method 
The infectious disease history of the patient and 
control groups (Toxoplasma gondii, Lyme) was 
determined by serological diagnostic methods. 
A commercial ELISA kit (Bio-Rad, France) 
was used for the detection of Toxoplasma 
gondii IgG and IgM antibodies. The presence of 
Lyme disease serology was assessed via ELISA 
(Anti-Borrelia IgG and IgM Generic Assay, 
Germany) in serum samples. All detection 
procedures were performed according to the 
manufacturer’s instructions. Presence of either 
or both IgG and IGM antibodies was accepted 
seropositive 
Sample size and statistical analysis 
For the sample size, it was determined that at 
least 50 subjects should be included in each 
group according to power analysis performed 
with the following parameters: 5% error 
margin, 80% power, an expected odds ratio of 
3 with a 50% frequency distribution of 
infection. 
The SPSS version 20 program was used for the 
analysis of all data. The Shapiro-Wilk test was 
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used to evaluate compliance with normal 
distribution. For continuous data, median, 
lowest and highest values (min-max) and/or 
mean ± standard deviation were preferred for 
the description of data, with respect to 
normality of distribution. The Mann Whitney U 
or Student's t-test was used for the comparison 
of continuous data between groups in the 
presence of non-normal and normal 
distribution, respectively. Pearson Chi-Square 
test was used for the comparison of categorical 
data. The p<0.05 threshold was defined as the 
level of significance. 
 
Results 
The study group consisted of 64 females and 
mean age was 45.5±13.1 (min-max: 15–76) 
years. The migraine and control groups were 
similar in terms of age (p=0.059) and gender 
distribution (p=0.211). 
Toxoplasma gondii positivity was detected in 
14 (28%) patients in the migraine group and in 
5 (%10) subjects in the control group. The 
frequency of Toxoplasma gondii positivity was 


















group compared to the control group 
(p=0.022). 
Lyme positivity was detected in 11 (19.6%) 
patients in the migraine group and in 8 (14.3%) 
subjects in the control group. There was again 
no significant difference between the groups 
(p=0.450) (Table 1). 
  
Discussion 
The present study, in which we aimed to 
determine whether there were relationships 
between migraine presence and intracellular 
pathogens, demonstrated that there was no 
difference between the migraine and control 
groups in terms of Lyme positivity frequency. 
However, of note, the frequency of Toxoplasma 
gondii positivity was higher in the migraine 
group compared to controls. 
In previous studies, Toxoplasma gondii has 
been shown to be a neurotrophic pathogen and 
is associated with neurological and 
neuropsychiatric symptoms [9-11]. In addition, 
the relationship between migraine, headache 
and Toxoplasma gondii has also received 


















Table 1. Age and gender characteristics and infection positivity frequencies of the study. 





Age, years, mean ± SD 44.3±15.23 47.5 ± 10.8    0.059 
Gender, n (%) 
         Female 




35 (70.0%)    0.211 
21 (42.0%) 15 (30.0%) 
Toxoplasma gondii, n (%) 
        Negative  





   0.022 
5 (10.0%) 14 (28.0%) 
Lyme (Borrelia burgdorferi), n (%) 
        Negative  





    0.275 
6 (12.0%) 10 (20.0%) 
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reported that this infection affects the levels of 
specific cytokines, causing edema in the brain, 
which may manifest as headaches [13,14]. In 
addition, in a study by Koseoglu et al., it was 
reported that Toxoplasma gondii was associated 
with migraine and was concluded that this 
infection may cause a neuroinflammatory 
process in the brain, thereby triggering 
migraine [8]. In a study comparing 105 patients 
with headache and 105 non-headache subjects, 
it was reported that the case and control group 
were similar in terms of Toxoplasma 
seropositivity [15]; however, interestingly, the 
level of IgG for Toxoplasma gondii was 
suggested to be associated with headache –even 
when the patient group included other types of 
headaches in addition to migraine (39 patients 
with migraine in the 105 subjects). Since this 
infection is very prevalent among humans, has 
a chronic characteristic in an estimated 30% of 
individuals [16] and the fact that the infection 
may persist in the brain [17], have supported the 
rationale of studies aiming to determine a 
relationship (if any) between headache and 
Toxoplasma gondii infection. One such study 
even suggested the introduction of serological 
testing for Toxoplasma gondii, after 
demonstrating that 11% of children with 
recurrent headaches had IgG positivity [12]. In 
a study from Brazil, wherein 261 cases with 
acute toxoplasmosis were investigated, 
headache frequency was reported to be the 
second most frequent symptom (after fever), 
and perhaps more interestingly, the distribution 
among sexes demonstrated a female-to-male 
ratio of 2.1 to 1 [18]. In the current study, to 
support the information in the literature, the 
frequency of Toxoplasma gondii positivity was 
significantly higher in patients with a diagnosis 
of migraine. We believe that these results 
indicate that the relationship between migraine 
and toxoplasmosis warrants further 
investigation, preferably in population-based 
studies. 
When Borrelia burgdorferi, the cause of Lyme 
disease, reaches the cerebral or spinal vessels, it 
attaches to endothelial cells. It has been 
reported that the direct and indirect effects of 
B.burgdorferi on the nervous system play a role 
in the formation of neuroborreliosis [19]. In a 
previous study, it was reported that B. 
burgdorferi invaded human neuronal and glial 
cells, remained alive and had no cytopathic 
effect on the host cell for up to seven days. It 
has been reported that this situation can lead to 
the escape of bacteria from the immune system 
and to long-term infections [20]. Various 
mechanisms have been reported in the literature 
regarding the transmission and action 
mechanisms of bacteria to the nervous system. 
Grab et al. reported that with the in vitro blood 
brain barrier model containing microvascular 
endothelial cells of the human brain, the 
passage of bacteria through the barrier depends 
on the ability of the bacteria to affect the Ca ++ 
signaling system in endothelial cells [21]. 
Cepok et al. reported that the early stage of B. 
burgdorferi meningoradiculitis is characterized 
by a well-coordinated immune response 
involving specific cytokine release and plasma 
cell uptake, followed by a prolonged, antigen-
specific B cell response in the central nervous 
system [22]. In the study of Rupprecht et al, it 
has been reported that chemokines (CXCL13) 
play a key role in attracting other immune cells 
to the inflammatory focus in Lyme 
neuroborreliosis, B cell migration to infection 
sites [23]. In the animal study of Pachner et al., 
Cytokines such as IL-6 have been reported to be 
important amplification molecules for 
cerebrospinal fluid inflammation in Lyme 
neuroborreliosis [24]. In Lyme disease, as a 
result of these changes in the central nervous 
system, it is expected that Lyme positivity in 
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migraine patients is higher than in the control 
group. It has been reported that Lyme disease 
causes various neurological symptoms such as 
headache and 15% of patients have 
neurological involvement [25,26]. Chronic 
headache associated with Lyme disease is 
difficult to diagnose and can be confused with 
primary or analgesic overuse headaches. 
However, it is important to make the correct 
diagnosis because when this symptom is 
associated with borreliosis, it tends to regress 
with antibiotic therapy [27-30]. In the study of 
Scelsa et al., it was reported that the incidence 
of new-onset headache was 53.06% and the 
incidence of migraine was 18.37% among 
patients hospitalized for recurrent neurological 
Lyme disease. In addition, it has been reported 
that all patients with meningitis or encephalitis 
requiring intravenous antibiotics have not only 
headache but also focal neurological findings or 
cognitive abnormalities [28]. In the current 
study, the migraine and control groups were 
similar in terms of Lyme disease frequency. 
However, few studies have investigated the 
possible relationship between Lyme disease 
and migraine. We believe it is very important to 
point out that the initial design and strength of 
the study may not be sufficient for such a post-
hoc analysis, and therefore we suggest that 
future studies should consider this possibility. 
The research has several limitations. One of its 
limitations is that the research is not 
community-based and has a single center. On 
the other hand, questioning the chronology of 
the onset of migraine and the positivity of these 
pathogens (Toxoplasma gondii, Borrelia 
burgdorferi) could enable us to see the 
relationship between migraine and the 
positivity of these pathogens more clearly. 
Despite these, this study is valuable because it 
is one of the few studies evaluating the 
relationship between migraine and Lyme 
disease and it shares results that support the 




In terms of the infections studied in the study 
group, there was statistically significant 
difference was found between patients with 
migraine and controls. However, further studies 
that enable comparisons by ensuring an 
infection distribution similar to that of the 
population are required. 
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